Targeting of tumor cells for human γδ T cells by nonpeptide antigens

Journal of Immunology

Volumn 167, Issue 9, 2001, Pages 5092-5098

  Kato, Y ^a   Tanaka, Y ^a   Miyagawa, F ^a   Yamashita, S ^a   Minato, N ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID; PYROPHOSPHATE; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BLAST CELL; BREAST CANCER; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN TARGETING; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL;

EID: 0035500925     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.9.5092     Document Type: Article

References (56)

1. γδ cells: A right time and a right place for a conserved third way of protection
2. γδ cells
3. Recognition of nonpeptide antigens by T cells
4. The structure, function, and molecular genetics of the γδ T cell receptor
5. CD3/TiγA: A functional γ-receptor complex expressed on human peripheral lymphocytes
6. Nonpeptide ligands for human γδ T cells
7. Natural and synthetic non-peptide antigens recognized by human γδ T cells
8. + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein
9. + T cells to Mycobacterium tuberculosis is restricted to Vγ9-bearing cells
10. Primary responses of human T cells to mycobacteria: A frequent set of γ/δ T cells are stimulated by protease-resistant ligands
11. Human γ/δ T cells responding to mycobacteria
12. + human γδ T cells
13. 3-Formyl-l-butyl pyrophosphate, a novel mycobacterial metabolite-activating human γδ T cells
14. A chemical basis for selective recognition of nonpeptide antigens by human γδ T cells
15. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands
16. Selection by two powerful antigens may account for the presence of the major population of human peripheral γ/δ T cells
17. Human γδ T cells recognize alkylamines derived from microbes, edible plants, and tea: Implications for innate immunity
18. γδ T-cell stimulation by pamidronate
19. Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma
20. Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human γδ T cells by aminobisphosphonate antigen
21. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function
22. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells
23. Human peripheral γδ T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested
24. Daudi lymphoma killing triggers the programmed death of cytotoxic Vγ9/Vδ2 T lymphocytes
25. Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer
26. Crucial role of TCR γ chain junctional region in prenyl pyrophosphate antigen recognition by γδ T cells
27. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells
28. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
29. The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma
30. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-γ/δ stimulated by nonpeptidic ligands
31. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vγ9Vδ2 T lymphocytes
32. Structure of a human γδ T-cell antigen receptor
33. The acute-phase response after bisphosphonate administration
34. Evaluation of adverse experiences related to pamidronate infusion in Paget's disease of bone
35. Different doses of pamidronate in patients with painful osteolytic bone metastases
36. Mechanisms of action of the bisphosphonates
37. High-dose intravenous pamidronate for metastatic bone pain
38. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy
39. Bisphosphonates: Mechanisms of action
40. Spontaneous resolution of a lung mass due to infection with Mycobacterium terrae
41. Tolerability of bacille Calmette-Guerin maintenance therapy for superficial bladder cancer
42. Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors
43. + antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidosis
44. T lymphocytes bearing the γδ T cell receptor in patients with acute Plasmodium falciparum malaria
45. Lymphocytosis of γ/δ T cells in human ehrlichiosis
46. Predominant expansion of Vγ9/Vδ2 T cells in a tularemia patient
47. Predominant activation and expansion of Vγ9-bearing γδ T cells in vivo as well as in vitro in Salmonella infection
48. Lymphocytes bearing the γδ T cell receptor in acute Brucella melitensis infection
49. In vivo and in vitro activation and expansion of γδ T cells during Listeria monocytogenes infection in humans
50. γδ T lymphocytes and proinflammatory cytokines in bacterial meningitis
51. Antigen-reactive γδ T cells in human leishmaniasis
52. Lymphocytes bearing the γδ T-cell receptor in acute toxoplasmosis
53. Vγ9Vδ2 T cells impair intracellular multiplication of Brucella suis in autologous monocytes through soluble factor release and contact-dependent cytotoxic effect
54. Vγ9/Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis
55. Expansion of Vγ9 Vδ2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination
56. γ/δ T cells provide innate immunity against renal cell carcinoma